SHP5

General Information


DRACP ID  DRACP05929

Peptide Name   SHP5

Sequence  NEAⓍYDIⓍFR

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides Induce apoptosis Tubulin Inhibitors



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Tubulin

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ(4) and Ⓧ (8) are cross-linked by hydrocarbon stapling

N-terminal Modification  FITC, 5(6)-carboxy fluorescence

C-terminal Modification  Free

Other Modification  Ⓧ=(S)-2-(4-pentenyl) Ala

Chiral  L



Physicochemical Information


Formula  C46H62N12O13

Absent amino acids  CGHKLMPQSTVW

Common amino acids  ADEFINRY

Mass  115178

Pl  4.18

Basic residues  1

Acidic residues  2

Hydrophobic residues  3

Net charge  -1

Boman Index  -2752

Hydrophobicity  -72

Aliphatic Index  49

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  165.56

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36240440

Title  Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors

Doi 0.1021/acs.jmedchem.2c01116

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.